Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer

by palligoelme@gmail.com | Dec 18, 2025 | Clinical Trials

​ Conditions: Oropharyngeal Cancer Interventions: Drug: Toripalimab; Drug: Carboplatin; Drug: Paclitaxel Sponsors: University of Chicago Not yet recruiting Conditions: Oropharyngeal Cancer Interventions: Drug: Toripalimab; Drug: Carboplatin; Drug: Paclitaxel Sponsors:...

Study Protocol: Cognitive, Emotional and Social Stimulation Programme for Low-SES Children.

by palligoelme@gmail.com | Dec 17, 2025 | Clinical Trials

​ Conditions: Child Development; Socioeconomic Factors Interventions: Other: Cognitive and emotional stimulation; Other: Random activities; Behavioral: Training for parents and teachers Sponsors: Joan Deus Yela; Cognifit; Universitat Autonoma de Barcelona; Universidad...

Opioid-Free Pain Management After NUSS Surgery in Adolescents

by palligoelme@gmail.com | Dec 17, 2025 | Clinical Trials

​ Conditions: Nerve Block Interventions: Procedure: Nerve block Sponsors: Qin Zhang Completed Conditions: Nerve Block Interventions: Procedure: Nerve block Sponsors: Qin Zhang Completed 

Functional Lung Avoidance Planning Guided by Lung Perfusion PET/CT Versus Anatomical Planning for Lung Stereotactic Body Radiotherapy

by palligoelme@gmail.com | Dec 17, 2025 | Clinical Trials

​ Conditions: Stereotactic Body Radiotherapy; 68Ga-MAA; Lung Cancer (Diagnosis) Interventions: Diagnostic Test: CT or 18F FDG PET/CT according to referent physician decision; Diagnostic Test: guided by lung perfusion PET/CT imaging Sponsors: University Hospital, Brest...

Safety, Tolerability, and Pharmacokinetics of SVG103 (Paxalisib) in Focal Cortical Dysplasia Type II (FCD-II), Tuberous Sclerosis Complex (TSC) or Hemimegalencephaly (HME)

by palligoelme@gmail.com | Dec 17, 2025 | Clinical Trials

​ Conditions: Focal Cortical Dysplasia; Tuberous Sclerosis Complex (TSC); Hemimegalencephaly Interventions: Drug: SVG103 Sponsors: SoVarGen Co., Ltd. Not yet recruiting Conditions: Focal Cortical Dysplasia; Tuberous Sclerosis Complex (TSC); Hemimegalencephaly...

Sarcopenia and NMIBC Prognosis Study

by palligoelme@gmail.com | Dec 16, 2025 | Clinical Trials

​ Conditions: Bladder Cancer Cell Transitional Sponsors: General Hospital Sveti Duh Not yet recruiting Conditions: Bladder Cancer Cell Transitional Sponsors: General Hospital Sveti Duh Not yet recruiting